ABSTRACT
Background Stroke survivors are at high risk of dementia, associated with increasing age and vascular burden and with pre-existing cognitive impairment, older age. Brain atrophy patterns are recognised as signatures of neurodegenerative conditions, but the natural history of brain atrophy after stroke remains poorly described. We sought to determine whether stroke survivors who were cognitively normal at time of stroke had greater total brain (TBV) and hippocampal volume (HV) loss over 3 years than controls. We examined whether stroke survivors who were cognitively impaired (CI) at 3 months following their stroke had greater brain volume loss than cognitively normal (CN) stroke participants.
Methods Cognition And Neocortical Volume After Stroke (CANVAS) study is a multi-centre cohort study of first-ever or recurrent adult ischaemic stroke participants compared to age- and sex-matched community controls. Participants were followed with MRI and cognitive assessments over 3 years and were free of a history of cognitive impairment or decline at inclusion. Our primary outcome measure was TBV change between 3 months and 3 years; secondary outcomes were TBV and HV change comparing CI and CN participants. We investigated associations between group status and brain volume change using a baseline-volume adjusted linear regression model with robust standard error.
Results Ninety-three stroke (26 women, 66.7±12 years) and 39 control participants (15 women, 68.7±7 years) were available at 3 years. TBV loss in stroke patients was greater than controls: stroke mean (M)=20.3cm3±SD14.8cm3; controls M=14.2cm3±SD13.2cm3; (adjusted mean difference 7.88 95%CI [2.84,12.91] p-value=0.002). TBV decline was greater in those stroke participants who were cognitively impaired (M=30.7cm3; SD=14.2cm3) at 3 months (M=19.6cm3; SD=13.8cm3); (adjusted mean difference 10.42; 95%CI [3.04,17.80], p-value=0.006). No statistically significant differences in HV change were observed.
Conclusions Ischaemic stroke survivors exhibit greater neurodegeneration compared to stroke-free controls. Brain atrophy is greater in stroke participants who were cognitively impaired people early after their stroke. Early cognitive impairment may predict greater subsequent atrophy, reflecting the combined impacts of stroke and vascular brain burden. Atrophy rates could serve as a useful biomarker for trials testing interventions to reduce post-stroke cognitive impairment.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
http://www.clinicaltrials.gov NCT02205424
Funding Statement
This work was supported by: NHMRC GNT1020526, GNT1045617(AB), GNT1094974; Brain Foundation; Wicking Trust; Collie Trust; Sidney and Fiona Myer Family Foundation; Australian Research Council DE180100893(NE) and Heart Foundation Future Leader Fellowship 100784(AB).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Austin Health HREC H2012-04650 was the central authority - protocol also approved at Eastern Health HREC (Box Hill Hospital) and Melbourne Health HREC (RMH)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data collected for this study is available on request to the authors. The study protocol was published in 2014 and is freely available. Data requests should be sent to the corresponding author and will be evaluated and approved after consultation with CANVAS chief investigators. One-year data (not part of this study) have already been shared with the ENIGMA Stroke Recovery consortium http://enigma.ini.usc.edu/ongoing/enigma-stroke-recovery/. We have committed to sharing CANVAS data with the STROKOG consortium. CANVAS also has a 5-year follow-up timepoint (not presented here). It is a requirement of the funding for this timepoint that it will be made publicly available once complete (expected completion and compilation late 2021 due to pandemic delays). This will include de-identified participant data including MRI data. Data will be shared at reasonable request following review by the CANVAS data steering committee.
Non-standard Abbreviations and Acronyms
- CANVAS
- Cognition And Neocortical Volume After Stroke
- CCI
- Charlson Comorbidity Index
- CDR
- Clinical Dementia Rating
- CI
- cognitively impaired
- CN
- cognitively normal
- HV
- hippocampal volume
- IQCODE
- Informant Questionnaire on Cognitive Decline in the Elderly Short Form
- NART
- National Adult Reading Test
- TBV
- total brain volume
